Literature DB >> 27150035

Compartmental modeling of [(11)C]MENET binding to the norepinephrine transporter in the healthy human brain.

Vikram Adhikarla1, Fanxing Zeng2, John R Votaw2, Mark M Goodman2, Jonathon A Nye3.   

Abstract

INTRODUCTION: Dysregulation of the noradrenergic system has been implicated in a number of neurological conditions such as Parkinson's and Alzheimer's. [(11)C]MENET is a novel PET radiotracer with high affinity and selectivity for the norepinephrine transporter. The applicability of different kinetic models on [(11)C]MENET PET image quantification in healthy population is evaluated.
METHODS: Six healthy volunteers (mean age: 54years) were recruited for the study, five of whom underwent arterial sampling for measurement of the input function. Ninety minute dynamic PET scans were obtained on a high resolution research tomograph with 15mCi of [(11)C]MENET injected at the scan start time. Regions of interest were delineated on the PET scan aided by the corresponding MRI image for anatomical guidance. Distribution volumes and their ratios (DVRs) with respect to the occipital reference tissue were calculated using the full arterial model (FAM), the simplified reference tissue model (SRTM) and the multilinear reference tissue model (MRTM2).
RESULTS: Among the FAMs, the single-tissue model was found to be statistically superior to the two-tissue model. [(11)C]MENET focal uptake was observed in the NET-rich regions of the brainstem and subcortical regions including the thalamus, locus cereleus and the raphe nuclei. Highest DVRs were observed in the locus cereleus (mean±standard deviation: 1.39±0.25) and red nucleus (1.35±0.25). DVRs of the thalamus were in good agreement between FAM (1.26±0.13), SRTM (1.23±0.15) and MRTM2 (1.21±0.14). Comparing the FAM to the SRTM and MRTM2, DVRs were underestimated in the thalamus by 3 and 4% on average, respectively.
CONCLUSION: The single-tissue compartmental model was sufficient in describing the [(11)C]MENET kinetics in the healthy human brain. SRTM and MRTM2 present themselves as attractive options for estimating NET DVR using an occipital reference region.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's; Norepinephrine; Norepinephrine transporter; Parkinson's; Positron emission tomography; Stress

Mesh:

Substances:

Year:  2016        PMID: 27150035      PMCID: PMC4860207          DOI: 10.1016/j.nucmedbio.2016.02.008

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  30 in total

Review 1.  Consensus nomenclature for in vivo imaging of reversibly binding radioligands.

Authors:  Robert B Innis; Vincent J Cunningham; Jacques Delforge; Masahiro Fujita; Albert Gjedde; Roger N Gunn; James Holden; Sylvain Houle; Sung-Cheng Huang; Masanori Ichise; Hidehiro Iida; Hiroshi Ito; Yuichi Kimura; Robert A Koeppe; Gitte M Knudsen; Juhani Knuuti; Adriaan A Lammertsma; Marc Laruelle; Jean Logan; Ralph Paul Maguire; Mark A Mintun; Evan D Morris; Ramin Parsey; Julie C Price; Mark Slifstein; Vesna Sossi; Tetsuya Suhara; John R Votaw; Dean F Wong; Richard E Carson
Journal:  J Cereb Blood Flow Metab       Date:  2007-05-09       Impact factor: 6.200

2.  Fluorine-18 Radiolabeled PET Tracers for Imaging Monoamine Transporters: Dopamine, Serotonin, and Norepinephrine.

Authors:  Jeffrey S Stehouwer; Mark M Goodman
Journal:  PET Clin       Date:  2009-01

3.  Motion artifact reduction on parametric PET images of neuroreceptor binding.

Authors:  Hans Herzog; Lutz Tellmann; Roger Fulton; Isabelle Stangier; Elena Rota Kops; Kay Bente; Christian Boy; Rene Hurlemann; Uwe Pietrzyk
Journal:  J Nucl Med       Date:  2005-06       Impact factor: 10.057

Review 4.  Noradrenergic mechanisms in the pathophysiology of post-traumatic stress disorder.

Authors:  T O'Donnell; K M Hegadoren; N C Coupland
Journal:  Neuropsychobiology       Date:  2004       Impact factor: 2.328

5.  An improved synthesis of [11C]MENET via Suzuki coupling with [11C]methyl iodide.

Authors:  Fanxing Zeng; Ronald J Voll; Ronald J Crowe; Michael S Waldrep; Karen B Dolph; Mark M Goodman
Journal:  J Labelled Comp Radiopharm       Date:  2013-04-24       Impact factor: 1.921

Review 6.  Dysfunction of the locus coeruleus-norepinephrine system and related circuitry in Parkinson's disease-related dementia.

Authors:  Kelly Del Tredici; Heiko Braak
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-10-13       Impact factor: 10.154

7.  Occupancy of serotonin and norepinephrine transporter by milnacipran in patients with major depressive disorder: a positron emission tomography study with [(11)C]DASB and (S,S)-[(18)F]FMeNER-D(2).

Authors:  Tsuyoshi Nogami; Harumasa Takano; Ryosuke Arakawa; Tetsuya Ichimiya; Hironobu Fujiwara; Yasuyuki Kimura; Fumitoshi Kodaka; Takeshi Sasaki; Keisuke Takahata; Masayuki Suzuki; Tomohisa Nagashima; Takaaki Mori; Hitoshi Shimada; Hajime Fukuda; Mizuho Sekine; Amane Tateno; Hidehiko Takahashi; Hiroshi Ito; Yoshiro Okubo; Tetsuya Suhara
Journal:  Int J Neuropsychopharmacol       Date:  2012-10-16       Impact factor: 5.176

Review 8.  The role of the noradrenergic system in emotional memory.

Authors:  Anda H van Stegeren
Journal:  Acta Psychol (Amst)       Date:  2007-12-19

Review 9.  Monoamine neurocircuitry in depression and strategies for new treatments.

Authors:  Michel Hamon; Pierre Blier
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2013-04-19       Impact factor: 5.067

Review 10.  The role of norepinephrine in epilepsy: from the bench to the bedside.

Authors:  Filippo S Giorgi; Chiara Pizzanelli; Francesca Biagioni; Luigi Murri; Francesco Fornai
Journal:  Neurosci Biobehav Rev       Date:  2004-09       Impact factor: 8.989

View more
  4 in total

Review 1.  Anti-stress neuropharmacological mechanisms and targets for addiction treatment: A translational framework.

Authors:  Mark K Greenwald
Journal:  Neurobiol Stress       Date:  2018-08-11

Review 2.  Noradrenergic Dysfunction in Alzheimer's and Parkinson's Diseases-An Overview of Imaging Studies.

Authors:  Andrew C Peterson; Chiang-Shan R Li
Journal:  Front Aging Neurosci       Date:  2018-05-01       Impact factor: 5.750

Review 3.  PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson's Disease.

Authors:  Gennaro Pagano; Tayyabah Yousaf; Marios Politis
Journal:  Curr Neurol Neurosci Rep       Date:  2017-10-03       Impact factor: 5.081

Review 4.  In vivo Brainstem Imaging in Alzheimer's Disease: Potential for Biomarker Development.

Authors:  David J Braun; Linda J Van Eldik
Journal:  Front Aging Neurosci       Date:  2018-09-11       Impact factor: 5.750

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.